OJOG  Vol.1 No.4 , December 2011
Comparison of two misoprostol regimens for cervical priming before surgical pregnancy termination at 13 to 16 weeks gestations
ABSTRACT
Background: The optimal regimen has still to be determined for the use of misoprostol in the surgical termination of pregnancy in the early second trimester. Objective: To compare the outcomes of two different regimens for cervical priming with misoprostol before dilatation and evacuation (D & E) in 13 weeks - 16 weeks gestation pregnancy terminations. Methods: A retrospective analysis was performed of the medical records of two cohorts of 334 women each who were treated with either 3 sublingual doses of 2 misoprostol 200 µg tablets 30 minutes apart on admission or the same dosage preceded by 1 oral tablet of misoprostol 200 µg at home 3 hours before admission. Results: The addition of the home tablet of misoprostol increased the rate of one day completion of D & E from 97.3% to 100% (P = 0.004), and the overall mean theatre time for D&E was reduced by 12.3% in parous women (P = 0.001) and 6.4% in nulliparous women (P = 0.003) with the reduction being consistent across all gestations. Conclusions: This retrospective study showed that the addition of 1 oral tablet of misoprostol 200 µg at home 3 hours before admission to a regimen of 3 sublingual doses of 2 misoprostol 200 µg tablets 30 minutes apart on admission significantly increases the probability of all women at 13 weeks - 16 weeks gestation completing a termination of pregnancy in one day with a single D & E procedure and with a reduced theatre time.

Cite this paper
nullChambers, D. , Willcourt, R. , Laver, A. , Baird, J. and Herbert, W. (2011) Comparison of two misoprostol regimens for cervical priming before surgical pregnancy termination at 13 to 16 weeks gestations. Open Journal of Obstetrics and Gynecology, 1, 187-190. doi: 10.4236/ojog.2011.14036.
References
[1]   Gamble, S.B., Strauss, L.T., Parker, W.Y., Cook, D.A., Zane, S.B. and Hamdan, S. (2008) Centers for disease control and prevention (CDC). Abortion Surveillance-United States 2005. MMWR Surveillance Summaries, 57, 1-32.

[2]   Aronsson, A., Bygdeman, M. and Gemzell-Danielsson, K. (2004) Effects of misoprostol on uterine contractility following different routes of administration. Human Reproduction, 19, 81-84. doi:10.1093/humrep/deh005

[3]   Chambers, D.G., Mulligan, E.C., Laver, A.R., Weller, B.K., Baird, J.K. and Herbert, W.Y. (2009) Comparison of four perioperative misoprostol regimens for surgical termination of first-trimester pregnancy. International Journal of Gynecology and Obstetrics, 7, 211-215. doi:10.1016/j.ijgo.2009.07.034

[4]   Pridmore, B.R. and Chambers, D.G. (1999) Uterine perforation during surgical abortion: Review of diagnosis, management and prevention. Australian and New Zealand Journal of Obstetrics and Gynaecology, 39, 349-353. doi:10.1111/j.1479-828X.1999.tb03413.x

[5]   Chambers, D.G., Willcourt, R.J., Laver, A.R., Baird, J.K. and Herbert, W.Y. (2011) Comparison of Dilapan-S and laminaria tents for cervical priming before surgical pregnancy termination at 17 to 22 weeks gestations. International Journal of Women’s Health, 3, 347-352. doi:10.2147/IJWH.S25551

[6]   Wilson, L.C., Meyn, L.A. and Creinin, M.D. (2011) Cervical preparation for surgical abortion between 12 and 18 weeks of gestation using vaginal misoprostol and Dilapan-S. Contraception, 8, 511-516. doi:10.1016/j.contraception.2010.10.004

[7]   Lohr, P.A., Hayes, J.L. and Gemzell-Danielsson, K. (2008) Surgical versus medical methods for second trimester induced abortion. Cochrane Database Systematic Reviews, 1, CD006714.

[8]   Carbonell, J.L., Gallego, F.G., Lorente, M.P., Bermudez, S.B., Sala, E.S., Gonzalez, L.V. and Texido, C.S. (2007) Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilatation and evacuation: A randomized clinical trial. Contraception, 75, 230-237. doi:10.1016/j.contraception.2006.11.007

[9]   Newman, S.J., Dalve-Endres, A., Diedrich, J.T., Steinauer, J.E., Meckstroth, K. and Drey, E.A. (2010) Cervical preparation for second trimester dilatation and evacuation. Cochrane Database Systematic Reviews, 8, CD007310.

[10]   Nucatola, D., Roth, N., Saulsberry, V. and Gatter, M. (2008) Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester surgical abortion (12 weeks - 16 weeks). Contraception, 78, 245-248. doi:10.1016/j.contraception.2008.04.121

 
 
Top